Combination of bevacizumab and bromfenac therapy in age-related macular degeneration: A pilot study

BACKGROUND: According to recent studies, the newest strategy for the treatment of exudative age-related macular degeneration is to combine anti-VEGF agents with non-steroid anti-inflammatory drugs (NSAIDs) such as nepafenac and bromfenac to decrease the frequency of intravitreal injections. Since mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyględowska-Promieńska, Dorota, Piotrowska-Gwóźdź, Anna, Piotrowska-Seweryn, Agnieszka, Mazur-Piotrowska, Grażyna, Rokicki, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Drug Controlled Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102605/
https://www.ncbi.nlm.nih.gov/pubmed/25006692
http://dx.doi.org/10.12659/MSM.890671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102605/
https://www.ncbi.nlm.nih.gov/pubmed/25006692
http://dx.doi.org/10.12659/MSM.890671

Ejemplares similares